EGFR and nasopharyngeal carcinoma: In CNE-2 cells (an NPC cell line), APP was upregulated by transforming growth factor-α (TGF-α) stimulation but had pretreatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor [46].